Accelus President & CEO Kevin McGann to Present at LSI USA '24 Conference
05 mars 2024 08h45 HE
|
Accelus
Accelus CEO Kevin McGann to speak at LSI USA '24, showcasing its leading spinal implants and recent successes, including a $55M Remi sale and $20M funding.
Accelus Strengthens Leadership with New Board Appointments
12 févr. 2024 08h45 HE
|
Accelus
Accelus Adds President & CEO Kevin McGann and High-Performance Management Expert Bernie Haffey to the Company's Board of Directors.
Accelus Introduces LineSider Modular-Cortical System for Posterior Fixation
29 janv. 2024 10h00 HE
|
Accelus
Accelus Introduces the LineSider Modular-Cortical System, offering greater procedural visibility, versatility and efficiency for posterior fixation
Accelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital
18 janv. 2024 08h15 HE
|
Accelus
Accelus has announced the closing of a $20 million debt facility with Symbiotic Capital.
Accelus Announces Renewed Focus on Pioneering Minimally Invasive Outpatient Procedures with Its Advanced Adaptive Geometry Technology
07 déc. 2023 08h23 HE
|
Accelus
Accelus announces a renewed focus on MIS with its innovative FlareHawk system for outpatient and awake lumbar fusion, aligning with 2024 trends.
Accelus Sells Remi Robotic Navigation System to Alphatec and Announces Leadership Change to Drive Growth and Innovation
19 avr. 2023 16h07 HE
|
Accelus
PALM BEACH GARDENS, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Announces FDA 510(k) Clearance of Remi Robotic Navigation System for Use with 2D Fluoroscopy-Based Imaging System
16 mars 2023 08h45 HE
|
Accelus
PALM BEACH GARDENS, Fla., March 16, 2023 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems
03 nov. 2022 08h45 HE
|
Accelus
PALM BEACH GARDENS, Fla., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
UPDATE -- Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System
18 oct. 2022 07h38 HE
|
Accelus
PALM BEACH GARDENS, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...
Accelus Announces Global Expansion of its FlareHawk Interbody Fusion System
18 oct. 2022 06h00 HE
|
Accelus
PALM BEACH GARDENS, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the...